← Evidence map

ArticleTranslational lung cancer research2025

XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

Misako Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40948839